its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake
#cagrilintide 2025-01-25
Saturday9 messages4 participantstimes are UTC
Highlights from this day
- deamidation — its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake 17:42
- bac_water_bill — the combination is the thing with trial data behind it, monotherapy in here is mostly us guessing 18:02
- typosquat_tay — follow up i titrated over twice as many weeks as i did on semaglutide and that was right for me 19:13
- deamidation — unrelated but noticed something around week 21 on monotherapy, well after i had given up expecting to 19:18
the combination is the thing with trial data behind it, monotherapy in here is mostly us guessing
did the combination change your GI compared to the GLP-1 alone
separate days
amylin not glp-1
the fullness effect hasnt faded over 9 months, unlike my semaglutide appetite curve
follow up i titrated over twice as many weeks as i did on semaglutide and that was right for me
genuine question does amylin do something about fullness that the GLP-1 doesnt
unrelated but noticed something around week 21 on monotherapy, well after i had given up expecting to